Forest Laboratories Inc

Forest Laboratories — Proxy Contest (August 2011)

31 slides from Forest Laboratories's proxy contest presentation, Aug 11, 2011

  1. Slide 1: Forest 2011 Annual Meeting website welcome

    jj£ Forest 2011 Annual Meeting — Windows Internet Explorer provided by SARD VERBINNEN & CO UV Vl ) w ^J http://www.frx2011annualmeeting.com..’ T ^ ^ X «’ GoogLe <P T : File Edit V’ieuv Favorites TcoIe Help ^ Favorites ^ Forest 2011 Annual Meeting /ZvSP Forest Laboratories* Inc. visitfrx.com f ^ _ |T

  2. Slide 2: Press Releases

    ‘(§ Press Releases | Forest 2011 Annual Meeting — Windows Internet Explorer provided by SARD VERBINNEN & CO J ^» ! ij5_, ht ±p:/..’vvvlvvv.frK2011annualmeeting.conn1rjre::-relea:e:.11 T ^ ^ X I - • ¦ Gvogle fl T File Edit View Favorites Tools Help <Q Favorites jfi preSs Releases | Forest 2011 Annual

  3. Slide 3: Forest Laboratories Sends Open Letter To Shareholders

    $ Forest Laboratories Sends Open Letter To Shareholders | Forest 2011 Annual Meeting — Windows Internet Explorer provided by SARD J ^» I ‘£_, ht ±p://vvWvv.fn^011annualnTeeting.com-’rjre::-relea:e:/fore:t-labcratorie5-:en(:l:-open-let ±er-to-:h arehckler:/ T ^ ^ X I - • ¦ Gvogle P T File Edit View F

  4. Slide 4: Forest Laboratories Sends Open Letter To Shareholders (continued)

    ^ Forest Laboratories Sends Open Letter To Shareholders | Forest 2011 Annual Meeting — Wmdows Internet Explorer provided by SARD J ^» I ‘£_, ht ±p://vvWvv.fn^011annualnTeeting.com-’rjre::-relea:e:/fore:t-labcratorie5-:en(:l:-open-let ±er-to-:h arehckler:/ T ^ ^ X I - • ¦ Gvogle P T File Edit View Fa

  5. Slide 5: Forest Laboratories Sends Open Letter To Shareholders (continued)

    %£ Forest Laboratories Sends Open Letter To Shareholders | Forest 20L1 Annual Meeting — Wmdows Internet Explorer provided by SARD J ^» I ‘£_, ht ±p://vvWvv.fn^011annualnTeeting.com-’rjre::-relea:e:/fore:t-labcratorie5-:en(:l:-open-let ±er-to-:h arehckler:/ T ^ ^ X I - • ¦ Gvogle P T File Edit View F

  6. Slide 6: Forest Laboratories Sends Open Letter To Shareholders (signatures)

    %£ Forest Laboratories Sends Open Letter To Shareholders | Forest 2011 Annual Meeting — Wmdows Internet Explorer provided by SARD Oi j ^ \’£_^ httpi/Avwvvin^Ollannualmeeting.com’preLL-releaGeL-Toreit-labcratorieL-LenclL-cpen-letter-tc-Lharehck ler:.- T ^ r^t X I «* Google P TI File | | View Favorite

  7. Slide 7: Forest Laboratories Sends Open Letter To Shareholders (additional information)

    ^ Forest Laboratories Sends Open Letter To Shareholders | Forest 2011 Annual Meeting — Wfndows Internet Explorer provided by SARD t3j V /* I ‘&. httpi/.’vvWvvin^Ollannualmeeting.com’preLL-releaGeL/foreit-laboratories-LenclL-open-letter-to-ihareh ckler:.- ^ ^ rt X I hj Googlf P T ‘ File Edit View Fav

  8. Slide 8: Forest Laboratories Sends Open Letter To Shareholders (contacts)

    ^ Forest Laboratories Sends Open Letter To Shareholders | Forest 2011 Annual Meeting — Wfndows Internet Explorer provided by SARD t3j V /* I ‘&. httpi/.’vvWvvin^Ollannualmeeting.com’preLL-releaGeL/foreit-laboratories-LenclL-open-letter-to-ihareh ckler:.- ^ ^ rt X I hj Googlf P T ‘ File Edit View Fav

  9. Slide 9: ISS Recommends Forest Shareholders Vote the Company's White Card

    jj£ ISS Recommends Forest Shareholders Vote the Company’s White Card at Annual Meeting | Forest 201 - Windows Internet Explorer pro [ nn | HB [^¦SJ^hJ .’ w ^j httpi/.Av^w.fn^Ollannualmeeting.com.^reGweleasei/icwec^ T ^ ^f X *v* Google <P T File Edit View Favorites Tools Help <Q Favorites ‘0 ISS Reco

  10. Slide 10: ISS Recommends Forest Shareholders Vote the Company's White Card (forward-looking)

    £ij£ ISS Recommends Forest Shareholders Vote the Company’s White Card at Annual Meeting | Forest 201 — Windows Internet Explorer pro [ nn | HB [^¦SJ^hJ .’ w ^j ht ±p://w^w.fn^011annualmeeting.com.’pre:welea:;e:/icwecommend:-fore:t-!;^^ T ^ ^f X *v* Google <P T File Edit View Favorites Tools Help <£

  11. Slide 11: ISS Recommends Forest Shareholders (voting assistance)

    £ij£ ISS Recommends Forest Shareholders Vote the Company’s White Card at Annual Meeting | Forest 201 — Windows Internet Explorer pro [ nn | HB [^¦SJ^h .’ w ^j ht ±p://w^w.frx2011annualmeeting.com.’pre:welea:;e:/icwecommend:-fore:t-^^ T ^ ^f X *v* Google <P T File Edit View Favorites Tools Help <£ Fa

  12. Slide 12: ISS Recommends Forest Shareholders (contacts)

    jj£ ISS Recommends Forest Shareholders Vote the Company’s White Card at Annual Meeting | Forest 201 - Windows Internet Explorer pro [ nn | HB [^¦SJ^hJ .’ w ^j ht ±p://w^w.frx2011annualmeeting.com.’pre:welea:;e:/icwecommend:-fore:t-!;h^ T ^ ^f X *v* Google <P T File Edit View Favorites Tools Help <Q

  13. Slide 13: Presentations & Materials

    H$ Presentations & Materials | Forest 2011 Annual Meeting — Windows Internet Explorer provided by SARD VERBINNEN & CO [ ¦=¦ | M !¦¦%» J v $2j http://www.frx2011annualmeeting.com¦¦’pre:entation!r-material:/ T ^ 4*f X \*M Gwgie <P T File Edit View Favorites Tools Help <£ Favorites ^ Presentations & Ma

  14. Slide 14: Presentations & Materials (letters and news reports)

    H$ Presentations & Materials | Forest 2011 Annual Meeting — Windows Internet Explorer provided by SARD VERBINNEN & CO [ ¦=¦ | M !¦¦%» J v $2j http://www.frx2011annualmeeting.com¦¦’pre:entation!r-material:/ T ^ 4*f X \*M Gwgie <P T File Edit View Favorites Tools Help <£ Favorites ^ Presentations & Ma

  15. Slide 15: Forest Labs Key Considerations for Shareholders

    Forest Labs Key Considerations for Shareholders August 11, 2011 aZvSx Forest Laboratories, Inc.

  16. Slide 16: Why You Should Support Forest's Nominees

    Why You Should Support Forest’s Nominees Forest is performing well, outperforming the relevant indices in both the short and long term and developing one of the deepest and most promising pipelines in the industry Forest nominees will create a strong and independent Board of Directors - six out of t

  17. Slide 17: Track Record of Financial Performance

    Track Record of Financial Performance(1) • Over the last 10 years, Forest has increased revenue at a compound annual growth rate of 12.1% - Commercial success has grown four products, CELEXA, LEXAPRO, BENICAR ® and NAMENDA, to blockbuster status with over $lBn in sales • Over this same time period,

  18. Slide 18: Delivering Shareholder Returns in Short & Long Term

    Delivering Shareholder Returns in Short & Long Term • We have outperformed the most relevant indices — the S&P 500 and the AMEX Pharmaceutical Index (DRG) — over both the short and long term Price Performance (1)(2) As of June 30, 2011 Forest S&P 500 DRG 1 Year 43.4% 28.1% 20.3% FRX Outperformance /

  19. Slide 19: Product Development Outperforming Industry

    Product Development Outperforming Industry • Forest has received 7 New Molecular Entities approvals over the last ten years and 4 in the last five years -outperforming many of its largest rivals NME + New BLA Approvals d)(2)(3)(4)(5) ^^^^^^^^^^^^^^^^^^^^^^^^^ 8 7 7 Peer Last 10 yrs Median: 7 2 2 2 2

  20. Slide 20: "Next Nine" Products Grow & Diversify Revenue

    “Next Nine” Products Grow & Diversify Revenue • New products will diversify Forest’s revenue mix significantly and allow a return to growth post the FY2012 Loss of Exclusivity of LEXAPRO - Top line sales growth goals of approximately 10% CAGR (‘13-’17); adjusted EPS growth goals of approximately 30%

  21. Slide 21: Highly Qualified Board with Strong Track Record

    Highly Qualified Board with Strong Track Record Over the last 10 years, the Company’s incumbent directors have guided Forest as revenues and earnings per share have increased at compound annual growth rates of 12.1% and 16.5% respectively Our slate represents an appropriate balance of new perspectiv

  22. Slide 22: Strong, New Independent Board Nominees

    Strong, New Independent Board Nominees Chris Coughlin, 59, most recently served as Executive Vice President and Chief Financial Officer of Tyco International from 2005 to 2010. Previously, Mr. Coughlin was Chief Financial Officer of Pharmacia Corporation from 1998 until its acquisition by Pfizer in

  23. Slide 23: Icahn's Nominees Should be Rejected

    Icahn’s Nominees Should be Rejected Richard Mulligan and Eric Ende have no previous corporate operating or management experience and have no expertise in compliance or governance. During Richard Mulligan’s six years of combined service as a director of ImClone, Biogen Idee and Enzon, none of these c

  24. Slide 24: We Believe Denner and Mulligan Are Conflicted

    We Believe Denner and Mulligan Are Conflicted Icahn doesn’t challenge the fact that Biogen Idee and Amylin compete with Forest for new product licensing and acquisition opportunities in important and overlapping therapeutic areas Icahn’s argument that Biogen Idee and Amylin do not currently market p

  25. Slide 25: Glass Lewis Rejects All But One of Icahn's Nominees

    Glass Lewis Rejects All But One of Icahn’s Nominees Glass Lewis recommends shareholders reject three of Icahn’s four nominees, thereby supporting nine of the Company’s ten nominees Forest respectfully disagrees with Glass Lewis’s support of Icahn-nominee Richard Mulligan. In supporting Mulligan, Gla

  26. Slide 26: Research Analysts Respect Forest's Accomplishments

    Research Analysts Respect Forest’s Accomplishments Corey Davis, Jefferies Research, 5/16/11: “Best late stage pipeline in all biopharma — 5 drugs launch in next 2 years all with composition of matter patents. Will drive >30% EPS growth post F2013 trough.” Ian Sanderson, Cowen Research, 10/18/10: “We

  27. Slide 27: Vote the White Proxy Card Today. Reject Icahn's Nominees!

    Vote the White Proxy Card Today. Reject Icahn’s Nominees! aZvSx Forest Laboratories, Inc.

  28. Slide 28: Important Additional Information: Forward Looking Information

    Important Additional Information Forward Looking Information Except for the historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertaint

  29. Slide 29: Important Additional Information: Non-GAAP Financial Information

    Important Additional Information Disclaimer re: Exclusivity Loss Management The Company’s successful management of the CELEXA loss of exclusivity does not guarantee successful management of future loss of exclusivity cycles (such as with respect to LEXAPRO and NAMENDA) or ability to replicate such r

  30. Slide 30: SEC Filings

    £P SEC Filings | Forest 2011 Annual Meeting — Windows Internet Explorer provided by SARD VERBINNEN & CO 1 ¦=¦ I & \ . w £Sj http://www.frx2011annualmeeting.com/sec-filings/ T ^ ^f X ^’ Google <P T : File Edit View Favorites Tools Help <£ Favorites gfi SEC Filings | Forest 2011 Annual Meeting /Xviay

  31. Slide 31: SEC Filings (continued)

    ££ SEC Filings | Forest 2011 Annual Meeting — Windows Internet Explorer provided by SARD VERBINNEN & CO [ ¦=¦ | jjl |mS» .’ w ^j http:/.AwvW.fnx2011annualmeeting.com-^ec-filincj:/ T ^ 4*f X \tM Gwgie <P T File Edit View Favorites Tools Help <£ Favorites gfi SEC Filings | Forest 2D11 Annual Meeting O

Forest Laboratories — Proxy Contest (August 2011) on 6ix